Glucagon receptor monoclonal antibody

Glucagon receptor monoclonal antibody has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 15, 2026: “Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on glucagon receptor monoclonal antibody

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Key Research and Development Program of China and 3 more
  • Animals1

What did studies of glucagon receptor monoclonal antibody find?

4

Studies of glucagon receptor monoclonal antibody measured 4 outcomes, among them progressive sperm motility, apoptosis and oxidative stress and ROS signaling.

Progressive sperm motility

upin mice1

1 study
  1. Glucagon receptor monoclonal antibody improves progressive sperm motility in mice.

    “In aged mice, the GCGR antibody improved progressive motility (P = 0.004)”

    Animalsmonoclonal antibodymales

    Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells

    Journal of translational medicine

Apoptosis

downin mice1

1 study
  1. Glucagon receptor monoclonal antibody decreases apoptosis in mice (streptozotocin-induced type 1 diabetes).

    “In diabetic mice, the GCGR antibody increased sperm concentration (P < 0.001) and reduced testicular oxidative stress and apoptosis.”

    Animalsstreptozotocin-induced type 1 diabetesmonoclonal antibodytestismales

    Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells

    Journal of translational medicine

More on Apoptosis

Oxidative stress and ROS signaling

downin mice1

1 study
  1. Glucagon receptor monoclonal antibody decreases oxidative stress and ROS signaling in mice (streptozotocin-induced type 1 diabetes).

    “In diabetic mice, the GCGR antibody increased sperm concentration (P < 0.001) and reduced testicular oxidative stress and apoptosis.”

    Animalsstreptozotocin-induced type 1 diabetesmonoclonal antibodytestismales

    Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells

    Journal of translational medicine

More on Oxidative stress and ROS signaling

Sperm concentration

upin mice1

1 study
  1. Glucagon receptor monoclonal antibody increases sperm concentration in mice (streptozotocin-induced type 1 diabetes).

    “In diabetic mice, the GCGR antibody increased sperm concentration (P < 0.001) and reduced testicular oxidative stress and apoptosis.”

    Animalsstreptozotocin-induced type 1 diabetesmonoclonal antibodymales

    Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells

    Journal of translational medicine

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months